Skip to main content
. 2014 Jun 3;14:395. doi: 10.1186/1471-2407-14-395

Figure 2.

Figure 2

Immunostaining for β-catenin. A) Immunostaining for β-catenin in oral basaloid squamous cell carcinoma (BSCC) showed weak cytoplasmic and nuclear immunopositivity. B) Well to moderately differentiated squamous cell carcinoma (W/MSCC) showed strong membranous, cytoplasmic and nuclear immunopositivity. C) Poorly differentiated squamous cell carcinoma (PDSCC) showed weak membranous, cytoplasmic and nuclear immunostaining. (A-C, immunohistochemistry β-catenin; original magnifications, A-C, ×400).